Skip to Content

PT Kalbe Farma Tbk ADR PTKFY

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, nutritionals, and distribution and logistics. The vast majority of the company's gross profits are derived from the nutritionals and prescription pharmaceuticals segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

Jalan Let. Jend. Suprapto Kav. 4, KALBE Building, Cempaka Putih
Jakarta, 10510, Indonesia
T +62 2142873888
Sector Healthcare
Industry Drug Manufacturers - General
Most Recent Earnings Sep 30, 2020
Fiscal Year End Dec 31, 2019
Stock Type
Employees 12,161